“Cagrilintide has human weight-loss evidence in defined studies.”

01 · Answer

Supported with scope

A phase 2 study examined cagrilintide alone. A later large study had separate cagrilintide-alone and CagriSema groups. The results apply only to each defined study group.

What kind of evidence this is

Randomized human outcomes. This answer uses a study that assigned people to groups by chance and measured a health outcome.

What this answer covers

Adults without diabetes. The 26-week study required BMI 30 or higher, or BMI 27 or higher with high blood pressure or unhealthy blood-fat levels. The 68-week study required BMI 30 or higher, or BMI 27 or higher with a weight-related health problem. All groups received food and activity guidance. Each result applies only to its study group and period. The CagriSema result does not establish the same result for cagrilintide alone. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.

Question type

Clinical outcomes. What a study measured about people's health, symptoms, or ability to function.